Junping Pei

State Key Laboratory Of Bioactive Molecules And Druggability Assessment, Guangzhou City Key Laboratory Of Precision Chemical Drug Development, #855 Xingye Avenue
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer.

Discovery of a Potent RXRγ Degrader WCF-598 for the Treatment of Castration-Resistant Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: March 20, 2026

Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1H-indole-3-yl)-5H-pyrrolo[2,3-b]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance.

Design, Synthesis and Biological Evaluation of 7-(1-Methyl-1H-indole-3-yl)-5H-pyrrolo[2,3-b]pyrazine Derivatives as Novel Covalent pan-FGFR Inhibitors to Overcome Clinical Resistance.

Journal: Journal of medicinal chemistry

Published: September 08, 2025

Lanosdracaenin A and (±)-Neodracaflavonoids A, Triterpenoid and Flavonoids with Anti-Inflammatory Activities from Dracaena cochinchinensis.

Lanosdracaenin A and (±)-Neodracaflavonoids A, Triterpenoid and Flavonoids with Anti-Inflammatory Activities from Dracaena cochinchinensis.

Journal: Organic letters

Published: August 05, 2025

Discovery of TBK1Molecular Glue Degraders as a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Discovery of TBK1Molecular Glue Degraders as a Potential Strategy for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Journal: Journal of medicinal chemistry

Published: June 06, 2025

A patent review of small molecular inhibitors targeting EGFR exon 20 insertion (Ex20ins) (2019-present).

A patent review of small molecular inhibitors targeting EGFR exon 20 insertion (Ex20ins) (2019-present).

Journal: Expert opinion on therapeutic patents

Published: December 21, 2024

Synthesis and Biological Activity of Tetracyclic Dispiro Core Derivatives of Natural Products Dispirocochlearoids A-C.

Synthesis and Biological Activity of Tetracyclic Dispiro Core Derivatives of Natural Products Dispirocochlearoids A-C.

Journal: Organic letters

Published: November 01, 2024

Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors.

Targeting EGFR with molecular degraders as a promising strategy to overcome resistance to EGFR inhibitors.

Journal: Future medicinal chemistry

Published: August 29, 2024

Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFRL858R/T790M/ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers.

Design, Synthesis, and Biological Evaluation of Dual Inhibitors of EGFRL858R/T790M/ACK1 to Overcome Osimertinib Resistance in Nonsmall Cell Lung Cancers.

Journal: Journal of medicinal chemistry

Published: February 07, 2024

Design, Synthesis, and Antitumor Activity of Potent and Selective EGFR L858R/T790M Inhibitors and Identification of a Combination Therapy to Overcome Acquired Resistance in Models of Non-small-cell Lung Cancer.

Design, Synthesis, and Antitumor Activity of Potent and Selective EGFR L858R/T790M Inhibitors and Identification of a Combination Therapy to Overcome Acquired Resistance in Models of Non-small-cell Lung Cancer.

Journal: Journal of medicinal chemistry

Published: April 12, 2023

A sulfhydryl blocking reagent BT-4 sensitizes cisplatin-based micelle prodrugs for efficient treatment of breast cancer.

A sulfhydryl blocking reagent BT-4 sensitizes cisplatin-based micelle prodrugs for efficient treatment of breast cancer.

Journal: International journal of pharmaceutics

Published: May 01, 2022

Emerging strategies to overcome resistance to third-generation EGFR inhibitors.

Emerging strategies to overcome resistance to third-generation EGFR inhibitors.

Journal: Journal of hematology & oncology

Published: March 23, 2022

Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.

Unraveling the Design and Discovery of c-Jun N-Terminal Kinase Inhibitors and Their Therapeutic Potential in Human Diseases.

Journal: Journal of medicinal chemistry

Published: February 24, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026